The benefits of renal denervation to treat severe hypertension are durable and consistent, three-year results from the SYMPLICITY HTN-2
trial of Medtronic’s Symplicity system demonstrate.
Medtronic Renal Denervation System Provides Durable Blood Pressure Benefits In Longest Trial To Date
The latest results from Medtronic’s SYMPLICITY HTN-2 trial show that patients treated for severe hypertension with the company’s Symplicity radio frequency renal denervation system showed a sustained reduction in blood pressure. The firm also announced the start of a renal denervation trial in patients with moderate hypertension.